{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:24:32Z","timestamp":1761578672622,"version":"3.41.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:p>Choosing an antithrombotic regime in patients with acute coronary syndrome (ACS) and a concomitant indication for anticoagulation is a challenge commonly encountered by clinicians. Our aim in this article is to evaluate the safety and efficacy of triple antithrombotic therapy (TT, anticoagulant plus dual antiplatelet) versus dual antithrombotic therapy [dual therapy (DT), anticoagulant plus single antiplatelet] in patients with ACS. We included all randomized trials comparing the outcomes of single versus dual antiplatelet therapy in patients with ACS on anticoagulants. The primary outcome was major adverse cardiac events (MACE). Other outcomes studied were all-cause mortality, cardiovascular mortality, myocardial infarction (MI), stroke, stent thrombosis (ST), and major bleeding. The Mantel-Haenszel risk ratio (RR) random-effects model was used to summarize data. Six studies, with a total of 11,437 patients, met our selection criteria. With a follow-up duration of 9\u201314 months, there was no significant difference between DT and TT in terms of MACE [RR 0.96; 95% confidence interval (CI), 0.79\u20131.17], all-cause mortality (RR 1.00; 95% CI, 0.77\u20131.29), cardiovascular mortality (RR 1.03; 95% CI, 0.79\u20131.34), MI (RR 1.14; 95% CI, 0.90\u20131.45), stroke (RR 0.83; 95% CI, 0.56\u20131.23), and ST (RR 1.32; 95% CI, 0.87\u20132.01). Compared with TT, DT was associated with significant reductions in major bleeding 4.1% versus 6.5% (RR 0.61; 95% CI, 0.45\u20130.81; number needed to treat = 42), clinically significant bleeding 10.5% versus 16.4% (RR 0.62; 95% CI, 0.48\u20130.80) and intracranial hemorrhage 0.4% versus 0.8% (RR 0.43; 95% CI, 0.24\u20130.77). In patients on anticoagulant therapy, the strategy of single antiplatelet therapy (DT) confers a benefit of less major bleeding with no difference in MACE, all-cause mortality, cardiovascular mortality, MI, stroke, and ST.<\/jats:p>","DOI":"10.1097\/crd.0000000000000320","type":"journal-article","created":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T08:50:59Z","timestamp":1621327859000},"page":"245-252","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Dual Versus Triple Therapy in Patients with Acute Coronary Syndrome and an Anticoagulation Indication: A Systematic Review with Meta-Analysis and Trial-Sequential Analysis"],"prefix":"10.1097","volume":"29","author":[{"given":"Rahul","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaqib H.","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Surgery, Adesh Medical College and Hospital, Kurukshetra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purva","family":"Ranchal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srikanth","family":"Yandrapalli","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brijesh","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West Virginia University School of Medicine, Morgantown, WV"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY"},{"name":"Division of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[{"name":"Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY"},{"name":"Division of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalaj","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical College of Wisconsin, Milwaukee, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,8,4]]},"reference":[{"key":"R1-20250619","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/eurheartj\/ehy396","article-title":"A Summary of the Joint Consensus Document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).","volume":"39","author":"Lip","year":"2018","journal-title":"Eur Heart J"},{"key":"R2-20250619","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/CIRCULATIONAHA.118.034722","article-title":"Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American Perspective-2018 update.","volume":"138","author":"Angiolillo","year":"2018","journal-title":"Circulation"},{"key":"R3-20250619","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial.","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"R4-20250619","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation.","volume":"377","author":"Cannon","year":"2017","journal-title":"N Engl J Med"},{"key":"R5-20250619","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI.","volume":"375","author":"Gibson","year":"2016","journal-title":"N Engl J Med"},{"key":"R6-20250619","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation.","volume":"380","author":"Lopes","year":"2019","journal-title":"N Engl J Med"},{"key":"R7-20250619","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"R8-20250619","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis.","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"R9-20250619","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2015.02.050","article-title":"Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: the ISAR-TRIPLE Trial.","volume":"65","author":"Fiedler","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R10-20250619","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jcin.2017.11.009","article-title":"Effect of procedure and coronary lesion characteristics on clinical outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the PIONEER AF-PCI Trial.","volume":"11","author":"Kerneis","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"R11-20250619","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1161\/CIRCULATIONAHA.119.043308","article-title":"Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome treated medically or with percutaneous coronary intervention or undergoing elective percutaneous coronary intervention: insights from the AUGUSTUS Trial.","volume":"140","author":"Windecker","year":"2019","journal-title":"Circulation"},{"key":"R12-20250619","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet"},{"key":"R13-20250619","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/hrt.2009.183822","article-title":"Relationship of functional mitral regurgitation to new-onset atrial fibrillation in acute myocardial infarction.","volume":"96","author":"Bahouth","year":"2010","journal-title":"Heart"},{"key":"R14-20250619","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.amjcard.2013.07.006","article-title":"New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry).","volume":"112","author":"Parashar","year":"2013","journal-title":"Am J Cardiol"},{"key":"R15-20250619","doi-asserted-by":"crossref","first-page":"e24964","DOI":"10.1371\/journal.pone.0024964","article-title":"Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography.","volume":"6","author":"Kralev","year":"2011","journal-title":"PLoS One"},{"key":"R16-20250619","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(07)61745-0","article-title":"Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study.","volume":"370","author":"S\u00f8rensen","year":"2007","journal-title":"Lancet"},{"key":"R17-20250619","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/17482940701882233","article-title":"Acute coronary syndromes in patients with prosthetic heart valves-a case-series.","volume":"10","author":"Iakobishvili","year":"2008","journal-title":"Acute Card Care"},{"key":"R18-20250619","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/eurheartj\/ehy162","article-title":"Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.","volume":"39","author":"Golwala","year":"2018","journal-title":"Eur Heart J"},{"key":"R19-20250619","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1016\/j.crvasa.2013.01.009","article-title":"Antithrombotic therapy in patients after valve surgery with special attention to the combination of anticoagulant and antiplatelet therapy.","volume":"55","author":"Brtko","year":"2013","journal-title":"Cor et Vasa"},{"key":"R20-20250619","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.amjmed.2017.03.057","article-title":"Safety and efficacy of dual versus triple antithrombotic therapy in patients undergoing percutaneous coronary intervention.","volume":"130","author":"Agarwal","year":"2017","journal-title":"Am J Med"},{"key":"R21-20250619","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijcard.2015.12.005","article-title":"Efficacy and safety of antithrombotic regimens after coronary intervention in patients on oral anticoagulation: traditional and Bayesian meta-analysis of clinical trials.","volume":"205","author":"Liu","year":"2016","journal-title":"Int J Cardiol"},{"key":"R22-20250619","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium.","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"R23-20250619","doi-asserted-by":"crossref","first-page":"647","DOI":"10.21037\/cdt.2018.06.09","article-title":"Antiplatelet agents in uncertain clinical scenarios-a bleeding nightmare.","volume":"8","author":"Esmonde","year":"2018","journal-title":"Cardiovasc Diagn Ther"},{"key":"R24-20250619","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/heartjnl-2019-314767","article-title":"Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves.","volume":"105","author":"Malik","year":"2019","journal-title":"Heart"},{"key":"R25-20250619","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.amjcard.2019.02.060","article-title":"Meta-analysis of direct-acting oral anticoagulants compared with Warfarin in Patients >75 Years of Age.","volume":"123","author":"Malik","year":"2019","journal-title":"Am J Cardiol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:00:51Z","timestamp":1750356051000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,4]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000320","relation":{},"ISSN":["1061-5377"],"issn-type":[{"type":"print","value":"1061-5377"}],"subject":[],"published":{"date-parts":[[2021,8,4]]}}}